10. July 2007 12:49
Actavis Group has announced that it has launched Terbinafine hydrochloride tablets in the U.S. Distribution of the product will commence immediately.
Terbinafine hydrochloride tablets, the generic equivalent of Novartis' Lamisil(R) tablets, will be available in 250 mg strength. Terbinafine hydrochloride tablets are indicated for the treatment of fungal infections of the fingernail and toenail.
Annual sales of terbinafine hydrochloride tablets in the U.S. were approximately US$687 million for the twelve months ending March 2007 according to IMS Health data.
http://www.actavis.com/
News-Medical.Net provides this medical information service in accordance
with these
terms and conditions.
Please note that medical information found
on this website is designed to support, not to replace the relationship
between patient and physician/doctor and the medical advice they may provide.